Epidemiology of invasive mycosis in ICU patients: A prospective multicenter study in 435 non-neutropenic patients

Intensive Care Medicine

Volumn 23, Issue 3, 1997, Pages 317-325

  Petri, M G ^a,b   Konig J ^b,c   Moecke, H P ^c,d   Gramm, H J ^d,e   Barkow, H ^e   Kujath, P ^e,f   Dennhart, R ^f,g   Schafer H ^e,g   Meyer, N ^e,h   Kalmar, P ^h,i   Thulig P ^i,j   Muller J ^j,k   Lode, H ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b City Hospital Zehlendorf/Heckeshorn   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d ASKLEPIOS KLINIK ALTONA   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g KRANKENHAUS NORDWEST   (Germany)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ Chirurgische Klinik   (Germany)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^k UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

Epidemiology; ICU patients; Invasive mycosis; Prospective multicenter study

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLUS; CANDIDA; FEMALE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYCOSIS; PERITONITIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDIASIS; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOSES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 8044222757     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050334     Document Type: Article

References (37)

1. Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy. Clin Infect Dis 7: 646-655
2. Beck-Sague CM, Jarvis WR (1993) The national nosocomial infections surveillance system: secular trends in the epidemiology of nosocomial fungal infections in the United States 1980-1990. J Infect Dis 167: 1247-1251
3. Meunier-Carpentier F, Kiehn TE, Armstrong D (1981) Fungemia in the immunocompromised host: changing pattern, antigenemia, high mortality. Am J Med 71: 363-370
4. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR (1991) Risk factors for candidemia in patients with acute lymphocytic leukemia. Clin Infect Dis 13: 211-215
5. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645
6. Schaberg DR, Culver DH, Gaynes RP (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med 91[Suppl 3B]:72s-75s
7. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheid WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD, Candidemia Study Group (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331: 1325-1330
8. McGowan JE Jr (1985) Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Clin Infect Dis 7[Suppl 3]:S357-S370
9. Bodey GP (1966) Fungal infections complicating acute leukemia. J Clin Epidemiol 19: 667-687
10. Hart PD, Russell E Jr, Remington JS (1969) The compromised host and infection: II. deep fungal infection. J Infect Dis 120: 169-189
11. Sandford GR, Merz WG, Wingard JR, Sarache P, Saral R (1980) The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 142: 503-509
12. Wenzel RP, Osterman CA, Donowitz LG, Hoyt JW, Sand MA, Martone WJ, Peacock JE Jr, Levine JI, Miller GB Jr (1981) Identification of procedure-related nosocomial infections in high-risk patients. Clin Infect Dis 3: 701-707
13. Maki DG (1989) Risk factors for nosocomial infection in intensive care - devices vs. nature and goals for the next decade. Arch Intern Med 149: 30-35
14. Craven DE, Kunches LM, Lichtenberg DA, Kollisch NR, Barry A, Heeren TC, McCabe WR (1988) Nosocomial infections and fatality in medical and surgical intensive care unit patients. Arch Intern Med 148: 1161-1168
15. Daschner F (1985) Nosocomial infections in intensive care units. Intensive Care Med 11: 284-287
16. Chandrasekar PH, Kruse JA, Mathews MF (1986) Nosocomial infection among patients in different types of intensive care units at a city hospital. Crit Care Med 14: 508-510
17. Emmerson AM (1990) The epidemiology of infections in intensive care units. Intensive Care Med 16 [Suppl 3]:S197-S200
18. Garvey BM, McCambley JA, Tuxen DV (1989) Effects of gastric alkalization on bacterial colonization in critically ill patients. Crit Care Med 17: 211-216
19. Füssle R, Biscoping J, Michaelis G, Zeiler D, Sziegoleit A (1991) Intensive care patients: a high risk population for Candida infections. Clin Intensive Care 2: 76-80
20. Füssle R, Biscoping, Zeiler D, Michaelis G, Sziegoleit A (1990) Mikrobiologische Betreuung von beatmeten Intensivpatienten: Möglichkeiten für Diagnostik und Therapie von pulmonalen Infekten. Anästh Intensivther Notfallmed 25: 491-496
21. Pellinen TJ, Valtonen VV, Luomanmäki K, Sivonen A, Virtanen KS (1983) The microbial colonization due to medical devices in intensive care patients with special emphasis on C. albicans. Ann Clin Res 15: 62-65
22. Burnie JP (1991) Developments in the serological diagnosis of opportunistic fungal infections. J Antimicrob Chemother 28 [Suppl A]:23-33
23. Müller J (1990) Laboratory diagnosis of deep-seated candidosis. Mycoses 33 [Suppl 1]:7-13
24. Müller J, Kappe R, Kubitza D, Fessier R, Scheidecker I (1987) The incidence of deep-seated mycoses in Freiburg im Breisgau. Mycoses 31[Suppl 1]:9-28
25. Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818-829
26. Goris RJA, te Boekhorst TPA, Nuytinck JKS, Gimbrere JSF (1985) Multiple-organ failure. Arch Surg 120: 1109-1115
27. SAS Institute (1989) SAS/STAT user's guide, 4th ed, vol 2, Version 6
28. Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, New York
29. Stone HH, Kolb LD, Currie CA, Geheber CE, Cuzzell JZ (1974) Candida sepsis: pathogenesis and principles of treatment. Ann Surg 179: 697-711
30. Pittet D, Monod M, Suter P, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill patients. Ann Surg 220: 751-758
31. Gaines JD, Remington JS (1972) Disseminated candidiasis in the surgical patient. Surgery 72: 730-736
32. Bodey GP, Anaissei EJ (1989) Chronic systemic candidiasis. Eur J Microbiol Infect Dis 8: 855-857
33. Gemeinhardt H, Deicke P (1989) Mykosen des Gefässsystems. In: Gemeinhardt H (ed) Endomykosen. Gustav Fischer, Stuttgart pp 327-329
34. Bennett JE (1978) Diagnosis and management of candidiasis in the immunosuppressed host. Scand J Infect Dis 16[Suppl]:63-67
35. Klein JJ, Watanakunakorn C (1979) Hospital-acquired fungemia: its natural course and clinical significance. Am J Med 67: 51-58
36. Bross J, Talbot GH, Maislin G, Hurwitz S, Storm BL (1989) Risk factors for nosocomial candidemia: a case control study in adults without leukemia. Am J Med 87: 614-620
37. Young RC, Bennett JE (1971) Invasive aspergillosis: absence of of detectable antibody response. Am J Respir Crit Care Med 104: 710-716